Found 534 hits.
| 340 | Maurer, M.+, Bork, K., Martinez-Saguer, I., Aygören-Pürsün, E., Botha, J., Andresen, I., and Magerl, M.: Management of patients with hereditary angioedema in Germany: comparison to other countries in the icatibant outcome survey. J. Eur. Acad. Dermatol. Venereol. 2019: 33; 163-169. IF: TBD (IF 2018: 5.11) |
| 296 | Ruft, J., Asady, A., Staubach, P., Casale, T., Sussman, G., Zuberbier, T., Maurer, M. Weller, K., and Altrichter, S.+: Development and validation of the cholinergic urticaria quality of life questionnaire: CholU-QoL. Clin. Exp. Allergy 2018: 48; 433-444. IF: 4.74 |
| 400. | Maurer, M.+, Costa, C., Giménez-Arnau, A., Guillet, G., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Savic, S., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin. Exp. Allergy 2020: 50; 1166-1175 IF: 5.02 |
o.400
| 235 | Inami, A., Matsuda, R., Grobosch, T., Komamura, H., Takeda, K., Yamada, Y., Miyake, M., Hiraoka, K., Maurer, M. Yanai, K., and Tashiro, M.+: A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers. Hum. Psychopharmacol. Clin. Exp. 2016: 31; 167-177. IF: 2.21 |
| 200 | Kay, A. B.+, Ying, S., Ardelean, E., MÅ‚ynek, A., Kita, H., Clark, P., and Maurer, M.: Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low level persistence in uninvolved skin. Brit. J. Dermatol. 2014: 171; 505-511. IF: 4.27 |
| 33 | Peters, E. M., Maurer, M. Botchkarev, V. A., deMasey Jensen, K., Welker, P., Scott, G. A., and Paus, R.+: Kit is expressed by epithelial cells in vivo. J. Invest. Dermatol. 2003: 121; 976-984. IF: 4.19 |
| 44 | Staubach, P., Onnen, K., Vonend, A., Metz, M., Siebenhaar, F., Tschentscher, I., Opper, B., Magerl, M., Lüdtke, R., Kromminga, A., and Maurer, M.+: Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: A placebo-controlled trial. Dermatology 2006: 212; 150-159. IF: 1.85 |
| 410. | Chen, Y., Yu, M., Huang, X., Tu, P., Shi, P., Maurer, M.+*, and Zhao, Z.+*: Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both. World Allergy Organ. J. 2021: 14; 100501. IF: 5.52 |
o.410
| 32. | Metz, M. and Maurer, M.: Innate immunity and allergy in the skin. Curr. Opin. Immunol. 2009: 21; 687-693. IF: 10.88 |
| 127 | Vukman, K. V., Visnovitz, T., Adams, P. N., Metz, M., Maurer, M. and O’Neill, S. M.+: Mast cells cultured from IL-3 treated mice show impaired responses to bacterial antigen stimulation. Inflamm. Res. 2012: 61; 79-85. IF: 1.96 |